Electromed, Inc. (ELMD)
| Market Cap | 85.63M |
| Revenue (ttm) | 32.17M |
| Net Income (ttm) | 3.68M |
| Shares Out | 8.55M |
| EPS (ttm) | 0.41 |
| PE Ratio | 24.27 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $9.95 |
| Previous Close | $10.31 |
| Change ($) | -0.36 |
| Change (%) | -3.49% |
| Day's Open | 10.31 |
| Day's Range | 9.92 - 10.31 |
| Day's Volume | 33,014 |
| 52-Week Range | 7.00 - 18.48 |
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its share...
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen ...
Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q1 2021 Results - Earnings Call Transcript
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial resu...
Value investors may want to consider the three stocks that are listed in this article, in my opinion, as they meet the below criteria:
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will i...
Electromed has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Here are some MedTech growth stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc.
Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q4 2020 Results - Earnings Call Transcript
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc.
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc.
Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q3 2020 Results - Earnings Call Transcript
In order to select the right breakout stock one has to first calculate its support and resistance level.
Coronavirus is going to be around for a while, so let's use it to define our investment strategies.
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.
The global financial markets are currently witnessing one of the worst periods since the Great Depression due to the coronavirus-led crisis.
Top Ranked Momentum Stocks to Buy for February 21st
As of late, it has definitely been a great time to be an investor of Electromed, Inc. (ELMD).
Electromed's (ELMD) CEO Kathleen Skarvan on Q2 2020 Results - Earnings Call Transcript
Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q1 2020 Results - Earnings Call Transcript
Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q4 2019 Results - Earnings Call Transcript
There is an activist driven initiative to enhance shareholder value.
Electromed, Inc. (ELMD) CEO Kathleen Skarvan on Q3 2019 Results - Earnings Call Transcript
About ELMD
Electromed develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with pers... [Read more...]
| Industry Medical Devices | IPO Date Aug 13, 2010 |
| CEO Kathleen S. Skarvan | Employees 120 |
| Stock Exchange NYSEAMERICAN | Ticker Symbol ELMD |
Financial Performance
In 2020, Electromed's revenue was $32.47 million, an increase of 3.74% compared to the previous year's $31.30 million. Earnings were $4.16 million, an increase of 110.14%.
Analyst Forecasts
According to 2 analysts, the average rating for Electromed stock is "Buy." The 12-month stock price forecast is 17.00, which is an increase of 70.85% from the latest price.